Results 111 to 120 of about 40,172 (184)

Employing the Oncolytic Vesicular Stomatitis Virus in Cancer Virotherapy: Resistance and Clinical Considerations. [PDF]

Viruses
Abdelmageed AA, Dewhurst S, Ferran MC.
europepmc   +1 more source

Vesicular Stomatitis Virus Pseudotypes [PDF]

Nature, 1972
openaire   +1 more source

Recombinant Oncolytic Vesicular Stomatitis Virus Expressing Mouse Interleukin-12 and Granulocyte-Macrophage Colony-Stimulating Factor (rVSV-dM51-mIL12-mGMCSF) for Immunotherapy of Lung Carcinoma. [PDF]

Int J Mol Sci
Ryapolova A, Zinovieva M, Vorona K, Krapivin B, Moroz V, Gasanov N, Imatdinov I, Imatdinov A, Ivanov R, Karabelsky A, Minskaia E.   +10 more
europepmc   +1 more source

Vesicular Stomatitis Virus: Insights into Pathogenesis, Immune Evasion, and Technological Innovations in Oncolytic and Vaccine Development. [PDF]

Viruses
Ahmed MM, Okesanya OJ, Ukoaka BM, Ibrahim AM, Lucero-Prisno DE.   +4 more
europepmc   +1 more source

The Small GTPase Ran Increases Sensitivity of Ovarian Cancer Cells to Oncolytic Vesicular Stomatitis Virus. [PDF]

Pharmaceuticals (Basel)
Geoffroy K, Viens M, Kalin EM, Boudhraa Z, Roy DG, Wu JH, Provencher D, Mes-Masson AM, Bourgeois-Daigneault MC.   +8 more
europepmc   +1 more source

A novel vesicular stomatitis virus armed with IL-2 mimic for oncolytic therapy. [PDF]

Virol Sin
Wu M, Wang Y, Wu C, Huang H, Zhou X, Wang J, Xiong S, Dong C.   +7 more
europepmc   +1 more source

Erratum: An HPLC-SEC-based rapid quantification method for vesicular stomatitis virus particles to facilitate process development. [PDF]

Mol Ther Methods Clin Dev
Schimek A, Ng JKM, Basbas I, Martin F, Xin D, Saleh D, Hubbuch J.   +6 more
europepmc   +1 more source

METTL3 depletion blocks vesicular stomatitis virus replication in pancreatic cancer cells through the establishment of an intrinsic antiviral state. [PDF]

J Virol
Catacalos-Goad C, Hawkins J, Krueger Q, Foret N, Grdzelishvili VZ.   +4 more
europepmc   +1 more source

Preclinical development of a replication-competent vesicular stomatitis virus-based Lassa virus vaccine candidate advanced into human clinical trials. [PDF]

EBioMedicine
Cooper CL, Morrow G, Yuan M, Postler TS, Neal ML, Cross RW, Woolsey C, Agans KN, Borisevich V, McNamara RP, Atyeo C, Roy V, Germosen D, Hou F, Li SL, Reiserova L, Choi Y, Wilson A, Wagner D, Wallace-Selman O, Carpov A, Geng F, Frederick DJ, DeStefano J, Ercolini AM, Enriquez AS, Hastie KM, Ramos da Silva S, Sayeed E, Coleman JW, Kilianski A, Alter G, Saphire EO, Aitchison JD, Geisbert TW, Gupta SB, Feinberg MB, Parks CL.   +37 more
europepmc   +1 more source

Chimeric Vesicular Stomatitis Virus Bearing Western Equine Encephalitis Virus Envelope Proteins E2-E1 Is a Suitable Surrogate for Western Equine Encephalitis Virus in a Plaque Reduction Neutralization Test. [PDF]

Viruses
Miazgowicz KL, Maloney BE, Brindley MA, Cassaday M, Petch RJ, Bates P, Brault AC, Calvert AE.   +7 more
europepmc   +1 more source